IBD is characterized by an impaired immune response, giving rise to gut chronic inflammation associated with an increased expression of mucosal vascular addressin cell adhesion molecule 1 (MADCAM1) and infiltrating CD4+ and α4β7 integrin+ T cells [18]. The gene discussed is MADCAM1; the disease is inflammatory bowel disease.